greeksoup/ stock research
Stock research / United States / Funds / Newtyn Management, LLC

Newtyn Management, LLC

CIK 1569241 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Newtyn Management, LLC reported 34 US-listed holdings worth $800.9 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: QuidelOrtho Corp. (14.5%), Theravance Biopharma Inc. (7.3%) and Indivior Pharmaceuticals, Inc. (6.7%). Against the quarter before, it opened 8 positions, added to 7, trimmed 13 and sold out of 7.

Reported holdings$800.9M-14.4% on Q1 2026
Positions34+1 on Q1 2026
The largest ten61.9%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
OpenedAdded toHeldTrimmed
QDEL14.5%TBPH7.3%INDV6.7%CNNE5.7%PAR5.3%WEAV5.1%TFX4.8%AIV4.5%MAGN4.1%OCTV3.9%XOMA3.8%RHLD3.7%BV3.4%PSIX2.9%20 more24.4%

The 14 largest of its 34 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $648.7 million in 39 positions$649MQ3 24Q4 2024: $574.3 million in 33 positions$574MQ4 24Q1 2025: $632.1 million in 31 positions$632MQ1 25Q2 2025: $660.0 million in 34 positions$660MQ2 25Q3 2025: $816.9 million in 33 positions$817MQ3 25Q4 2025: $945.3 million in 31 positions$945MQ4 25Q1 2026: $935.8 million in 33 positions$936MQ1 26Q2 2026: $800.9 million in 34 positions$801MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +2.0% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
100110120130Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +2.0%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 8Added 7Held 6Trimmed 13Sold out 7
Opened: 8Added: 7Held: 6Trimmed: 13Sold out: 7

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 8

  1. Octave Intelligence PLC Ord SHS Class B OCTV$31.3 million
  2. Xoma Royalty Corporation XOMA$30.1 million
  3. Power Solutions PSIX$23.4 million
  4. Global Med REIT Inc. XRN$15.2 million
  5. Enviri Corp. NVRI$8.2 million
  6. Fundrise Innovation FD LLC VCX$3.5 million
  7. Zooz Strategy Ltd ZOOZ$3.0 million
  8. Enhanced Group Inc - US ENHA$286,994

Added to 7

  1. QuidelOrtho Corp. QDEL+2.1 million shares · +45%
  2. Green Dot Corp. GDOT+1.1 million shares · +744%
  3. Seritage Growth Pptys SRG+2.2 million shares · +5411%
  4. Elme Communities ELME+2.2 million shares · +706%
  5. Rocket Pharmaceuticals Inc. RCKT+834,100 shares · +26%
  6. Cogent Communications Holdings, Inc. CCOI+55,895 shares · +3%
  7. Magnera Corp. Com SHS MAGN+40,000 shares · +1%

Trimmed 13

  1. United States Cellular Corp. AD-1.0 million shares · -63%
  2. Indivior Pharmaceuticals, Inc. INDV-694,205 shares · -35%
  3. Theravance Biopharma Inc. TBPH-1.4 million shares · -29%
  4. Teleflex Inc. TFX-95,000 shares · -24%
  5. Resolute Holdings Manag RHLD-40,000 shares · -17%
  6. Par Technology Corp. PAR-313,942 shares · -11%
  7. Compass Minerals Intl Inc. CMP-137,674 shares · -18%
  8. Atai Beckley NV ATAI-593,895 shares · -33%

and 5 more in the table below

Sold out of 7

  1. Enviri Corp. NVRI$108.0 million last quarter
  2. Commscope Hldg Co. Inc. VISN$68.5 million last quarter
  3. USA Rare Earth Inc. USAR$35.4 million last quarter
  4. Destiny TECH100 Inc. Com SHS DXYZ$9.2 million last quarter
  5. Ultragenyx Pharmaceutical in RARE$8.4 million last quarter
  6. Zooz PWR Ltd ZOOZ$4.0 million last quarter
  7. Uniqure NV QURE$1.4 million last quarter

What it holds

CompanySharesValueOf its bookChange in shares
QuidelOrtho Corp. QDEL6.6M$116.0 million14.49%+2.1M
Theravance Biopharma Inc. TBPH3.4M$58.4 million7.29%-1.4M
Indivior Pharmaceuticals, Inc. INDV1.3M$53.6 million6.69%-694.2K
Cannae Hldgs Inc. CNNE3.2M$45.6 million5.70%-97.3K
Par Technology Corp. PAR2.4M$42.1 million5.26%-313.9K
Weave Communications Inc. WEAV6.8M$40.7 million5.08%-210.0K
Teleflex Inc. TFX305.0K$38.7 million4.83%-95.0K
Apartment Invt & Mgmt Co. AIV12.2M$36.2 million4.52%no change
Magnera Corp. Com SHS MAGN2.8M$32.9 million4.11%+40.0K
Octave Intelligence PLC Ord SHS Class B OCTV1.9M$31.3 million3.91%new
Xoma Royalty Corporation XOMA709.2K$30.1 million3.76%new
Resolute Holdings Manag RHLD202.4K$29.3 million3.65%-40.0K
Brightview Hldgs Inc. BV1.9M$27.5 million3.43%-160.0K
Power Solutions PSIX600.9K$23.4 million2.92%new
Cogent Communications Holdings, Inc. CCOI1.7M$23.0 million2.87%+55.9K
United States Cellular Corp. AD597.1K$21.7 million2.70%-1.0M
Compass Minerals Intl Inc. CMP632.3K$19.7 million2.46%-137.7K
Green Dot Corp. GDOT1.2M$16.3 million2.03%+1.1M
Spectrum Brands Hldgs Inc. Ne SPB185.0K$15.9 million1.98%no change
Global Med REIT Inc. XRN406.4K$15.2 million1.90%new
Rocket Pharmaceuticals Inc. RCKT4.0M$13.7 million1.71%+834.1K
1 800 Flowers Com Inc. FLWS3.5M$12.2 million1.52%no change
Ni Hldgs Inc. NODK670.0K$10.5 million1.31%no change
Grail, Inc. GRAL150.0K$10.2 million1.28%no change
Enviri Corp. NVRI374.2K$8.2 million1.03%new
Atai Beckley NV ATAI1.2M$6.3 million0.78%-593.9K
Seritage Growth Pptys SRG2.3M$6.0 million0.74%+2.2M
Elme Communities ELME2.5M$3.7 million0.46%+2.2M
Franklin STR Pptys Corp. FSP7.2M$3.7 million0.46%no change
Fundrise Innovation FD LLC VCX40.0K$3.5 million0.43%new
Zooz Strategy Ltd ZOOZ537.5K$3.0 million0.37%new
Wave Life Sciences Ltd WVE215.0K$1.2 million0.16%-85.0K
Mereo Biopharma Group PLC MREO3.0M$953,1000.12%-4.1M
Enhanced Group Inc - US ENHA100.0K$286,9940.04%new
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 7 it sold out of are in the box above.